Parent and group
- BIONERGA100%
- NUHMA AC53.2%
- NUTSBEDRIJVEN HOUDSTERMAATSCHAPPIJ100%
From the official registers: KBO 8 annual accounts at the National Bank publications in the Belgian Official Gazette
BIOSTOOM BELGIË is a financial institution. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €60.7m and a net result of €5.9m. Equity has been growing by about 23% per year since 2018. Its solvency ranks better than 67% of 3,028 sector peers (NACE 64, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals.
The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The company filed its last 7 accounts on average 75 days before the deadline. In the sector (NACE 64), the median for financial year 2024 was 14 days before the deadline, and 28% of those companies filed late.
These companies have the same main activity as BIOSTOOM BELGIË: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €57m and €102m, founded between 2013 and 2019.
| Company | Total assets | Turnover |
|---|---|---|
| BIOSTOOM BELGIË Hasselt | €76.5m | €3.8m |
| I-CARE HOLDING Mons | €86.2m | €3.5m |
| Hyloris Pharmaceuticals Liège | €101.5m | €3.8m |
| GOLAZO Beringen | €92.0m | €3.7m |
| Tech Tribes Antwerpen | €92.2m | €2.9m |
| Vydraulics Moorslede | €56.5m | €3.2m |
| Sereni Group Antwerpen | €79.1m | €5.6m |
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.